TrialPloS one2017

The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation.

Sue Wells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.